Back to Articles
Metabolic November 19, 2026 18 min read4,962 words

Buy GLP-1(7-36) Amide | Vendors, Price & Purity Guide

Trying to source GLP-1(7-36) amide for research? This guide covers verified vendors, price benchmarks, COA reading, and every red flag to avoid.

BP

BuyPeptidesOnline Editorial

Research & Science Team

You've done the background reading. You understand that GLP-1(7-36) amide — the endogenous 30-amino-acid incretin released from intestinal L-cells within minutes of a meal — is one of the most pharmacologically significant gut hormones in metabolic research. You know it binds the GLP-1 receptor (GLP-1R) with picomolar affinity, drives glucose-dependent insulin secretion, slows gastric emptying, and has a half-life of roughly 1.5–2 minutes in plasma due to rapid DPP-4 cleavage. You've probably already read our GLP-1(7-36) dosage and protocol guide.

What you need now is practical intelligence: which vendors actually sell the real thing, what a legitimate certificate of analysis looks like for this specific peptide, what you should pay per milligram, and how to spot the low-purity junk that floods the research chemical market. That's exactly what this article covers.

GLP-1(7-36) amide is a technically demanding peptide to synthesize correctly. The C-terminal amide group is non-trivial to install cleanly during solid-phase peptide synthesis (SPPS), and the sequence contains multiple residues prone to racemization under aggressive coupling conditions. Vendors who cut corners produce product that looks fine on a mass spec but fails in bioassays — and you'd never know unless you tested it yourself. The market for this peptide has grown significantly alongside the explosion of interest in GLP-1 receptor agonist pharmacology, which means more vendors, more counterfeits, and more critical need for this guide.

Let's get into it.

---

Why Sourcing GLP-1(7-36) Amide Is Harder Than It Looks

Most peptide buyers have a mental model of sourcing that goes: find a vendor with good reviews, check their COA, order. For many peptides — BPC-157, TB-500, Ipamorelin — that model works reasonably well. These are relatively short, structurally robust sequences with well-established synthesis protocols and a large number of experienced manufacturers.

GLP-1(7-36) amide breaks that model in several ways.

First, the C-terminal amide. The native peptide terminates in a glycine amide (Gly³⁶-NH₂), not a free carboxyl. This matters biologically — the amide is required for full GLP-1R binding affinity, and the free acid form (GLP-1(7-36)-OH) is significantly less potent. Many low-tier manufacturers either produce the free acid and mislabel it, or produce a mixture. A mass spec won't easily distinguish these without careful fragmentation analysis, and a basic HPLC trace won't catch it at all.

Second, the sequence length. At 30 amino acids, GLP-1(7-36) amide sits in the zone where synthesis errors compound. Truncated sequences, deletion peptides (sequences missing one or more internal residues), and oxidized methionine at position 17 are all real contamination risks. Each one looks like a minor impurity on a low-resolution HPLC trace but represents a biologically inactive or differently-active molecule.

Third, DPP-4 sensitivity. The N-terminal His⁷-Ala⁸ dipeptide is the primary DPP-4 cleavage site. This means your peptide can degrade even before you use it if storage conditions are inadequate — and some vendors ship lyophilized peptide that has already undergone partial degradation in their own storage. A COA showing 98% purity at manufacture tells you nothing about what's in the vial when it arrives at your lab.

Fourth, the regulatory shadow. GLP-1(7-36) amide occupies a legally complex space. It's an endogenous human peptide, sold for research purposes only, but its close structural relationship to FDA-approved drugs like Semaglutide, Liraglutide, and Exenatide means some vendors are cautious about selling it, and others are reckless about marketing it. The FDA has taken enforcement action against vendors making therapeutic claims about GLP-1-related peptides. Legitimate vendors know this and keep their language appropriately research-focused.

Understanding these four challenges is the foundation for evaluating any vendor you're considering.

---

What Legitimate GLP-1(7-36) Amide Actually Costs

Price is one of the most useful vendor-vetting signals, but only if you know the real market range. Here's what the current market looks like for research-grade GLP-1(7-36) amide:

QuantityLow-Quality / UnverifiedMid-Tier (HPLC only)High-Quality (HPLC + MS + COA)
1 mg$25–$45$55–$85$90–$140
5 mg$80–$150$200–$320$350–$550
10 mg$140–$250$350–$550$600–$950
25 mg$280–$500$750–$1,100$1,200–$1,800
50 mg$450–$750$1,200–$1,800$2,000–$3,000

These ranges reflect the US market as of 2025–2026. If a vendor is pricing GLP-1(7-36) amide at significantly below the mid-tier range, something is wrong — either the purity specs are weak, the C-terminal chemistry is incorrect, or you're buying a heavily degraded or mislabeled product. Peptide synthesis at scale with proper quality control is expensive. You cannot synthesize, purify, test, lyophilize, and ship a verified 30-mer amide peptide for $30/mg and make money.

Conversely, pricing alone doesn't guarantee quality. Some vendors charge premium prices for mediocre product. Always cross-reference price with documentation.

Bulk pricing becomes relevant for labs running multiple experiments. At 25–100 mg quantities, most established vendors offer 15–25% volume discounts. Custom synthesis orders (>100 mg) are negotiated directly and typically require 3–6 weeks lead time from a reputable manufacturer.

---

The Five Vendor Tiers: Where GLP-1(7-36) Amide Suppliers Actually Fall

Not all peptide vendors are created equal, and the market has stratified into fairly clear tiers over the past few years. Here's how to map the landscape:

Tier 1: US-Based, Third-Party Tested, COA-First Vendors

These are the vendors serious research labs use. They distinguish themselves by:

•

Independent third-party HPLC and MS analysis: — not just in-house testing

•

Full sequence verification by mass spectrometry, not just molecular weight confirmation

•

C-terminal amide confirmation explicitly stated in the COA

•

Batch-specific COAs accessible by lot number on their website

•

Clear research-use-only language and no therapeutic claims

•

Responsive technical support that can answer specific questions about synthesis method and purity testing protocols

Vendors in this tier typically manufacture through partnerships with established US or EU peptide synthesis facilities operating under ISO 9001 or GMP-adjacent standards. They don't necessarily hold GMP certification themselves (which would require FDA oversight and isn't applicable to research-use peptides), but their manufacturing partners do.

Expect to pay Tier 1 prices — roughly $90–$140/mg for 1–5 mg quantities. You're paying for documentation, batch traceability, and the vendor's reputation on the line.

Tier 2: US-Based, In-House Tested, Established Vendors

The second tier includes vendors with solid reputations and years of operation who test in-house rather than through independent labs. Their HPLC data is generally reliable, and mass spec confirmation is usually available. The gap versus Tier 1 is primarily independent verification — you're trusting their quality control process rather than having it externally audited.

For many research applications, Tier 2 vendors are entirely adequate. The risk is slightly higher for technically demanding peptides like GLP-1(7-36) amide where synthesis complexity makes QC gaps more consequential.

Tier 3: International Vendors (China/India-Based), Variable Quality

A large portion of the global peptide research market is served by Chinese and Indian manufacturers and the US/EU-based resellers who source from them. Quality here is genuinely variable — the best Chinese synthesis facilities (Bachem China, CS Bio, and several others) produce peptides that rival any Western manufacturer. The worst produce barely-characterized material at rock-bottom prices.

The key issue with direct-from-China sourcing for GLP-1(7-36) amide is documentation reliability. COAs from some Chinese vendors are generated post-hoc or are fabricated outright. If you're ordering from this tier, independent verification of at least one batch is essential before relying on vendor-supplied data.

Pricing in this tier is attractive — often 40–60% below Tier 1 for comparable stated purity. Whether that purity is real is the question.

Tier 4: Gray-Market / Unverified Vendors

These vendors typically operate through generic-looking websites, offer very low prices, lack verifiable company addresses or phone numbers, and provide COAs that are either absent, generic (not batch-specific), or clearly templated. Some operate through marketplaces like eBay or Alibaba with minimal accountability.

For GLP-1(7-36) amide specifically, this tier is high-risk. The peptide's structural complexity means the probability of receiving a degraded, truncated, or misidentified product is substantial. Avoid entirely for any application where data quality matters.

Tier 5: Compounding Pharmacies (Prescription-Only, US)

For human use in clinical research contexts, FDA-registered compounding pharmacies represent the most tightly regulated source. However, these require a valid physician prescription, operate under state pharmacy board oversight, and are not accessible to most basic science researchers. Pricing is substantially higher and access is restricted.

This guide focuses primarily on Tiers 1–3, which represent the accessible research market.

---

How to Read a GLP-1(7-36) Amide Certificate of Analysis

A COA is only as useful as your ability to interpret it. Here's what to look for specifically for this peptide — not generic COA-reading advice, but GLP-1(7-36) amide-specific requirements.

1. Peptide Identity Confirmation

The COA should state the full IUPAC name or the sequence: His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH₂. The -NH₂ at the end is non-negotiable. If the COA shows a free acid terminus (-OH) or simply doesn't specify, that's a red flag.

The molecular formula should be C₁₅₃H₂₂₅N₃₇O₄₆ with a molecular weight of 3297.7 Da (monoisotopic: 3295.6 Da). Any significant deviation from this warrants investigation.

2. HPLC Purity Data

Look for:

•

Purity ≥ 95%: by area percentage (RP-HPLC). Most legitimate vendors targeting research use report ≥97–98%.

•

The column type and gradient conditions should be specified. Generic "HPLC: >95%" without method details is insufficient.

•

The chromatogram itself should be included or available on request. A single sharp main peak with small flanking impurity peaks is what you want. Multiple peaks of similar height, or a main peak with a large shoulder, indicates significant impurity content.

•

UV detection wavelength: should be specified — typically 214 nm or 220 nm for peptide bond absorption.

3. Mass Spectrometry Confirmation

This is where GLP-1(7-36) amide COAs separate the serious vendors from the rest. You want:

•

ESI-MS or MALDI-TOF: data confirming the correct molecular ion

•

For ESI-MS: multiply-charged ions consistent with a 3297.7 Da peptide (e.g., [M+4H]⁴⁺ at ~825.4 Da, [M+5H]⁵⁺ at ~660.5 Da)

•

Ideally, MS/MS fragmentation data or sequence coverage confirming internal sequence integrity

•

C-terminal amide verification: — some vendors include specific fragmentation analysis confirming the -NH₂ terminus

A COA with only HPLC data and no MS confirmation is insufficient for a 30-mer amide peptide. If the vendor claims this level of testing isn't necessary, find a different vendor.

4. Residual Solvents and Endotoxin Testing

For in vitro cell work or in vivo rodent studies, these matter:

•

Residual solvents: (acetonitrile, TFA) should be below ICH Q3C limits

•

Endotoxin testing: (LAL assay) should show <1 EU/mg for any in vivo application

•

Sterility testing: is relevant for injectable preparations

Many research-grade vendors don't routinely run endotoxin testing unless requested. If your research protocol involves in vivo administration, ask explicitly — and be willing to pay a small premium for endotoxin-tested batches.

5. Water Content

Lyophilized peptides contain variable amounts of water and residual TFA (from HPLC purification). Karl Fischer titration water content and TFA content (by ion chromatography or NMR) affect the actual peptide content per milligram of powder. A vial labeled "5 mg" that contains 15% water and 8% TFA actually contains only ~3.85 mg of peptide. Legitimate vendors report net peptide content (NPC) or provide correction factors.

🔬 COA Red Flag: Any certificate that doesn't report NPC or water content for a lyophilized peptide is likely overstating the actual peptide quantity you're receiving. For GLP-1(7-36) amide at these price points, this matters.

---

Vendor Vetting: The 12-Point Checklist

Before placing any order for GLP-1(7-36) amide, run through this checklist:

Documentation Quality

•

[ ] Batch-specific COA (not generic product COA)

•

[ ] COA accessible by lot number on vendor website — not just emailed on request

•

[ ] HPLC chromatogram included or available

•

[ ] MS data confirming molecular weight and C-terminal amide

•

[ ] Net peptide content reported

Company Legitimacy

•

[ ] Physical US/EU address verifiable (not a PO box)

•

[ ] Company has been operating for ≥3 years with consistent reputation

•

[ ] No FDA warning letters or import alerts in their history

•

[ ] Research-use-only language throughout website; no therapeutic claims

Technical Competence

•

[ ] Technical support can answer specific questions about synthesis method (Fmoc SPPS vs. Boc, coupling reagents, purification method)

•

[ ] Vendor explicitly states C-terminal amide form

•

[ ] Independent third-party testing verification available (Tier 1) or in-house with methodology disclosed (Tier 2)

If a vendor fails more than two of these points, move on. There are enough legitimate options in this market that settling for a marginal supplier isn't necessary.

---

Independent Verification: When and How to Test Your Peptide

Even with a verified Tier 1 vendor, independent verification makes sense in several scenarios:

•

You're establishing a new vendor relationship for the first time

•

You're running a high-stakes experiment where peptide quality directly affects publishable results

•

You've ordered a large batch (>10 mg) and want to confirm quality before using it all

•

Results from a previous batch were inconsistent with published literature

Third-Party Testing Options

Academic core facilities: Many universities with chemistry or biochemistry departments operate analytical core facilities that offer HPLC and MS services. Turnaround is typically 1–3 weeks. Cost: $50–$200 per sample depending on analysis type. This is the most accessible option for academic researchers.

Commercial analytical labs: Companies like Covance, Charles River Analytical, SGS, and Intertek offer peptide purity analysis. More expensive than academic cores ($200–$500 per sample) but faster turnaround and more standardized reporting.

Specialized peptide testing services: A handful of companies specifically serve the research peptide market with analytical testing. They understand the specific requirements for 30-mer amide peptides and can provide C-terminal amide confirmation. Turnaround: 5–10 business days. Cost: $150–$350.

What to request: At minimum, RP-HPLC purity analysis and ESI-MS molecular weight confirmation. If budget allows, add amino acid analysis (AAA) to confirm composition and net peptide content. Full sequence verification by MS/MS is the gold standard but typically costs $400–$800 and is only warranted for critical experiments.

DIY Bioactivity Screening

If you have access to GLP-1R-expressing cell lines (e.g., INS-1 cells, HEK293 cells stably expressing human GLP-1R), a simple cAMP accumulation assay provides a functional bioactivity readout that no analytical chemistry can substitute for. A genuine GLP-1(7-36) amide preparation should produce an EC₅₀ of approximately 0.5–2 nM in a GLP-1R/cAMP assay. Significantly higher EC₅₀ values (>10 nM) suggest degradation, incorrect terminus, or sequence errors.

This type of bioactivity testing is rarely feasible for most buyers, but if you're running pharmacology experiments where receptor potency is the primary variable, it's worth the effort.

---

Ordering Logistics: Practical Details That Matter

Minimum Order Quantities and Standard Pack Sizes

Most vendors offer GLP-1(7-36) amide in standard pack sizes of 1 mg, 5 mg, and 10 mg. Some offer 0.5 mg vials for researchers who only need small quantities for pilot experiments. Custom quantities are available from most Tier 1 and Tier 2 vendors but typically require 2–4 weeks lead time.

For most in vitro cell culture experiments, 1 mg is sufficient for dozens of experiments (typical working concentrations are 1–100 nM in nanoliter to microliter volumes). For in vivo rodent studies, 5–10 mg is a more realistic starting point depending on dosing protocol and number of animals.

Shipping Considerations

GLP-1(7-36) amide is a lyophilized powder that is relatively stable at room temperature for short periods, but best practice is cold-chain shipping. Legitimate vendors ship with:

•

Dry ice or cold packs: for shipments expected to take >2 days

•

Vacuum-sealed vials: under inert atmosphere (argon or nitrogen)

•

Desiccant packs: inside the shipping container

Some vendors offer standard shipping (no cold chain) for lyophilized peptides under the argument that lyophilized peptides tolerate ambient temperature transit. This is partially true — properly lyophilized GLP-1(7-36) amide can tolerate 24–48 hours at room temperature without significant degradation. However, for maximum security, cold-chain shipping is worth the additional cost (~$15–$30).

International shipping for GLP-1(7-36) amide carries regulatory complexity. While the peptide itself is not a controlled substance in most jurisdictions, customs can flag peptide shipments for inspection, particularly from China. US-based vendors shipping domestically avoid this issue. European researchers sourcing from US vendors may face import documentation requirements.

Payment Methods and Vendor Accountability

Most legitimate peptide vendors accept credit cards, PayPal, or cryptocurrency. A vendor that only accepts cryptocurrency or wire transfer is a significant red flag — this payment structure is specifically designed to make chargebacks and fraud recovery impossible. Legitimate businesses accept reversible payment methods because they're confident in their product.

That said, some reputable vendors offer cryptocurrency discounts (5–10%) as a payment option alongside traditional methods. That's different from cryptocurrency-only.

---

Reconstitution, Storage, and Handling: Protecting Your Investment

You've sourced high-quality GLP-1(7-36) amide. Now the most common way researchers destroy their investment is poor reconstitution and storage practice.

Reconstitution Protocol

GLP-1(7-36) amide dissolves readily in aqueous buffers. Recommended approach:

1. Allow the vial to equilibrate to room temperature before opening (15–20 minutes). Opening a cold lyophilized vial introduces condensation that can cause clumping and uneven dissolution.

2. Add sterile, nuclease-free water or PBS (pH 7.4) slowly to the vial wall, not directly onto the lyophilized cake. For most applications, a stock concentration of 1 mg/mL is practical.

3. Gently swirl — do not vortex. Vortexing 30-mer peptides can cause mechanical shearing and aggregation.

4. Allow 5–10 minutes for complete dissolution with occasional gentle rotation.

5. Filter through a 0.22 μm membrane if sterility is required for cell culture or in vivo use.

For longer-term storage of reconstituted peptide, adding 0.1% BSA as a carrier protein significantly reduces adsorption to plastic surfaces and improves stability. This is particularly important at very low concentrations (<100 nM) where peptide adsorption to tube walls becomes a significant source of error.

Storage Conditions

FormConditionExpected Stability
Lyophilized, sealed-20°C24–36 months
Lyophilized, sealed4°C12–18 months
Lyophilized, opened-20°C6–12 months
Reconstituted, aqueous-80°C6–12 months
Reconstituted, aqueous-20°C1–3 months
Reconstituted, aqueous4°C3–7 days
Reconstituted, aqueousRoom tempHours only

Critical: avoid repeated freeze-thaw cycles. Each cycle causes mechanical stress on the peptide structure and accelerates aggregation. Aliquot reconstituted stock into single-use volumes before freezing. For a 1 mg vial reconstituted to 1 mg/mL, 50 μL aliquots work well for most protocols.

DPP-4 inhibition: For in vitro experiments studying native GLP-1(7-36) amide bioactivity, include a DPP-4 inhibitor (e.g., sitagliptin at 10 μM, or diprotin A at 100 μM) in your working solution to prevent enzymatic degradation during the experiment. This is standard practice in GLP-1 pharmacology research and significantly improves assay reproducibility.

---

Common Scams and Red Flags in the GLP-1 Peptide Market

The GLP-1 space specifically has attracted bad actors because of the enormous consumer interest in GLP-1 receptor agonists for weight management. Here are the specific scam patterns researchers encounter:

The "GLP-1 Peptide" Bait-and-Switch

Some vendors advertise "GLP-1 peptide" at very low prices but ship a completely different compound — often a GLP-1 fragment, a scrambled sequence, or simply a cheap generic peptide. Without MS confirmation, you'd never know. This is more common in the consumer wellness market than the research chemical market, but it happens.

The Degraded Stock Dump

Some vendors accumulate old stock — peptide that has been stored improperly or is approaching its end of shelf life — and sell it at discounts. The COA shows the purity at manufacture (years ago), not the current state. Always check the manufacture date on the COA and ask about storage conditions between manufacture and shipping. Any batch manufactured more than 24 months ago should be treated with skepticism unless cold-chain storage documentation is provided.

The Free-Acid Substitution

As mentioned above, GLP-1(7-36)-OH (free acid form) is cheaper to synthesize than the amide form. Some vendors sell the free acid labeled as the amide, or produce a mixture. Functionally, the free acid has approximately 10-fold lower GLP-1R affinity than the amide form, meaning your dose-response curves will be shifted right and your EC₅₀ values will look wrong compared to published literature.

The Inflated Purity Claim

Some vendors report purity by a method that systematically overestimates it — for example, using a UV detection wavelength where impurities absorb poorly, or using gradient conditions that don't adequately resolve deletion peptides. A stated purity of 98% by one method might be 85% by a more rigorous method. This is why method disclosure on the COA matters.

The "GMP Grade" Claim Without Substance

Several vendors claim "GMP grade" or "pharmaceutical grade" for research peptides. In the US, GMP certification for peptides requires FDA oversight and is only applicable to drug products — not research chemicals. A research-use peptide vendor cannot legitimately hold GMP certification for their research-use products. This claim is either technically meaningless (they manufacture under GMP-like conditions without certification) or outright misleading. Ask specifically: what certification body issued the GMP certification and what facility does it cover?

---

Researchers sometimes need to decide between native GLP-1(7-36) amide and structurally related peptides for their experimental design. Here's how they compare on sourcing-relevant dimensions:

FeatureGLP-1(7-36) AmideExenatideLiraglutideSemaglutide
StructureNative human, 30-mer amideExendin-4 analog, 39-merFatty acid-modified GLP-1 analogPEGylated GLP-1 analog
GLP-1R affinity~0.5–2 nM~0.1–0.5 nM~0.1 nM~0.03 nM
Plasma half-life~1.5–2 min (native)~2.4 hours~13 hours~7 days
Synthesis complexityHigh (amide terminus)Very high (39-mer)Very high (fatty acid conjugation)Extremely high (PEG chemistry)
Research availabilityGoodGoodModerateGood
Price per mg$90–$140$80–$130$150–$250$120–$200
Primary research useMechanism studies, receptor pharmacologyIn vivo efficacy, diabetes modelsIn vivo efficacy, metabolic studiesClinical translation models
COA complexityHigh (amide confirmation required)HighVery highVery high

For pure receptor pharmacology studies — binding assays, cAMP accumulation, receptor internalization — native GLP-1(7-36) amide is the gold standard because it represents the endogenous ligand. For in vivo metabolic studies requiring sustained effects, Exenatide or Liraglutide are more practical due to their longer half-lives. For translational research most relevant to current clinical GLP-1 drugs, Semaglutide and Tirzepatide are the obvious choices.

---

Building a Reliable Supply Chain for Ongoing Research

For labs running sustained GLP-1 research programs, a single-vendor approach creates supply risk. Vendors discontinue products, change manufacturing partners, have quality control lapses, or run out of stock. Here's a pragmatic supply chain approach:

Primary Vendor + Backup Vendor Model

Identify one Tier 1 vendor as your primary source. Build a relationship with their technical team — introduce yourself, explain your research application, ask specific questions. Established vendors value academic relationships and often provide better technical support to researchers they know.

Simultaneously, qualify a Tier 2 backup vendor. Run a head-to-head quality comparison with your first order — same analytical tests on product from both vendors. Once you've confirmed the backup vendor's quality is acceptable, maintain them as an alternative.

Batch Reserve Strategy

For critical experiments, order enough product from a single batch to complete the full experimental series. Between-batch variability — even from the same vendor — is real. Keeping a 20–30% reserve from a quality-verified batch ensures you can complete your study on consistent material.

Documentation Practices

Maintain a vendor file for each supplier that includes:

•

All COAs received, organized by batch number

•

Any independent analytical results

•

Shipping and receipt documentation

•

Performance notes (did results match expected pharmacology?)

•

Communication records with technical support

This documentation becomes invaluable if you need to troubleshoot unexpected experimental results or if a reviewer questions your peptide source.

---

Price Negotiation and Bulk Purchasing Strategy

Researchers who plan to use significant quantities of GLP-1(7-36) amide over 12+ months should consider negotiating directly with vendors rather than purchasing off-the-shelf.

What to ask for:

•

Volume pricing for committed annual purchase quantities

•

Custom synthesis with specified purity minimums (>98% by RP-HPLC, >95% by MS/MS)

•

Endotoxin testing included in the price

•

Batch reservation — vendor holds a specific batch for you while you verify quality

•

Extended shelf-life guarantee with free replacement if the product degrades before the stated shelf life

Most Tier 1 and Tier 2 vendors will negotiate on price for committed volume. A lab committing to 50+ mg over 12 months should expect 20–35% below catalog price. The key is demonstrating that you're a serious, ongoing customer rather than a one-time buyer.

Custom synthesis is worth considering for quantities above 50 mg. Direct engagement with a synthesis facility (bypassing the vendor markup) can reduce cost by 30–50% at large scale. The tradeoff is more project management burden and the need for your own analytical verification infrastructure.

---

Regulatory Context: What You Need to Know Before Ordering

GLP-1(7-36) amide is sold as a research chemical for in vitro and in vivo research use only in the United States. It is not approved for human use, and purchasing it with intent to self-administer is illegal and dangerous (the rapid DPP-4 degradation in plasma makes subcutaneous injection of native GLP-1(7-36) amide essentially ineffective anyway — this is exactly why pharmaceutical GLP-1 drugs are engineered analogs).

The regulatory landscape for GLP-1-related peptides has become more complex since 2023, when the FDA took enforcement actions against compounding pharmacies producing semaglutide and other GLP-1 analogs without proper oversight. While these actions targeted pharmaceutical compounders rather than research chemical vendors, they signal heightened regulatory attention to the GLP-1 space generally.

For legitimate researchers:

•

Institutional procurement through a university or research institution purchasing system adds a layer of documentation and legitimacy

•

IACUC approval for in vivo studies is required regardless of peptide source

•

IRB approval for any human subjects research is required — no research-grade peptide should ever be used in human subjects

•

Import documentation may be required for international shipments; consult your institution's import/export compliance office

---

Questions to Ask Any Vendor Before Buying

Here are the specific questions that separate vendors who know their product from those who don't:

1. "Can you confirm the C-terminal amide form is guaranteed in your COA?" A legitimate vendor answers yes immediately and points to the specific COA field. A bad vendor hedges or pivots to discussing purity percentage.

2. "What is the net peptide content of your current batch?" They should give you a specific number (e.g., 87.3%) and explain how it was determined (Karl Fischer for water, ion chromatography for TFA).

3. "What is the lot number of current stock and when was it manufactured?" Any vendor with real inventory tracking answers this instantly.

4. "Is your HPLC data generated in-house or by a third party? Can I have the method details?" Tier 1 vendors name their third-party lab. Tier 2 vendors provide method details. Red-flag vendors give vague answers.

5. "What is your replacement or refund policy if independent testing shows purity below the stated specification?" Confident vendors have clear policies. Vendors with inferior product deflect.

6. "Have you had any FDA communications or warning letters related to your products?" Legitimate vendors answer honestly. This is public information anyway — you can check the FDA's warning letter database.

---

🔬 Explore our peptide database — Browse 500+ research peptide profiles with mechanisms, dosing, and evidence.
🛒 Ready to buy? — Browse our verified vendor shop for third-party tested peptides.
🤖 Have questions? — Ask PeptideAI for personalized peptide guidance.
📚 Want more guides? — Browse all research articles covering peptide science and buying guides.

---

Key Takeaways

•

GLP-1(7-36) amide requires C-terminal amide confirmation: on the COA — this is non-negotiable and distinguishes the active form from the less potent free acid.

•

Expect to pay $90–$140/mg: for verified, third-party tested product. Prices significantly below this range signal quality problems.

•

Batch-specific COAs with HPLC chromatograms and ESI-MS data: are the minimum documentation standard for a 30-mer amide peptide of this complexity.

•

Net peptide content (NPC): must be reported — lyophilized peptides contain water and TFA that reduce actual peptide content per vial.

•

Tier 1 US-based vendors: with independent third-party testing provide the most reliable product for pharmacology research; Tier 2 vendors are adequate for many applications if method transparency is high.

•

Independent verification: is warranted for new vendor relationships, large batch purchases, or critical experiments — academic core facilities provide affordable HPLC/MS analysis.

•

DPP-4 inhibitor co-treatment: is essential for in vitro bioactivity assays to prevent degradation during the experiment.

•

Aliquot reconstituted peptide: immediately and avoid freeze-thaw cycles — each cycle degrades peptide integrity.

•

Cryptocurrency-only payment: and lack of verifiable company address are reliable red flags for fraud.

•

The FDA enforcement environment: around GLP-1-related compounds is active — use legitimate research channels, maintain documentation, and never use research-grade peptides in humans.

---

Frequently Asked Questions

What is the difference between GLP-1(7-36) amide and GLP-1(7-36) free acid?

The amide form has a C-terminal -NH₂ group required for full GLP-1 receptor binding, while the free acid (-OH) has approximately 10-fold lower receptor affinity. Always confirm the amide form on the COA before purchasing.

How much should I expect to pay for research-grade GLP-1(7-36) amide?

Expect $90–$140/mg for 1–5 mg quantities from a verified, third-party tested US vendor. Prices significantly below this range typically indicate inferior purity, incorrect terminus, or degraded stock.

What should a legitimate GLP-1(7-36) amide COA include?

A legitimate COA must include batch-specific HPLC purity (≥95%), ESI-MS molecular weight confirmation (3297.7 Da), explicit C-terminal amide confirmation, net peptide content, and manufacture date.

How do I store GLP-1(7-36) amide after reconstitution?

Aliquot reconstituted peptide into single-use volumes and store at -80°C for up to 12 months or -20°C for 1–3 months. Avoid repeated freeze-thaw cycles, which accelerate aggregation and degradation.

Is it legal to buy GLP-1(7-36) amide online?

Yes, for legitimate research purposes. It is sold as a research chemical for in vitro and in vivo research use only in the US and is not approved for human use. Purchasing for self-administration is illegal.

Why does my GLP-1(7-36) amide show a higher EC50 than published literature?

The most common causes are: receiving the free acid form instead of the amide, peptide degradation by DPP-4 during the assay (add a DPP-4 inhibitor like sitagliptin at 10 μM), or peptide adsorption to plastic tubes at low concentrations (add 0.1% BSA).

How can I independently verify the purity of GLP-1(7-36) amide I've purchased?

Submit a sample to a university analytical core facility or commercial lab for RP-HPLC and ESI-MS analysis. Cost is typically $50–$350 depending on the service. Functional bioactivity testing in GLP-1R/cAMP assays should show an EC50 of 0.5–2 nM for genuine product.

What is net peptide content (NPC) and why does it matter for GLP-1(7-36) amide?

NPC is the actual peptide mass per mg of lyophilized powder, accounting for residual water (measured by Karl Fischer) and TFA. A vial labeled 5 mg with 15% water and 8% TFA actually contains ~3.85 mg peptide — NPC disclosure ensures accurate dosing.

buy GLP-1 7-36 amide onlineGLP-1 7-36 amide vendor guideGLP-1 peptide where to buyGLP-1 7-36 amide purity testingresearch peptide GLP-1 COAGLP-1 amide vs free acidbest GLP-1 peptide supplierGLP-1 7-36 amide price per mgGLP-1 peptide certificate of analysislegitimate GLP-1 research peptideGLP-1 7-36 reconstitution storageGLP-1 peptide vendor red flags

Ready to take the next step?

Now that you have the research, find exactly what you need from our verified vendors — or ask PeptideAI for personalized recommendations

Looking for more? Buy peptides online from the #1 peptide research platform.